Bristol Myers Squibb Deploys Claude AI to 30,000+ Employees for Drug Development on May 20

According to Guru Club, Bristol Myers Squibb announced on May 20 that it is partnering with Anthropic to deploy the Claude AI model to more than 30,000 employees to accelerate drug discovery, development, and commercialization. The company will also utilize Anthropic's Claude Code programming tool and evaluate its applications in research, drug development, manufacturing, and other commercial and medical operations.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments